Gene · 11280
Papers1,589
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,589
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Dynamic Control of Band Alignment and Built-In Potential in High Performance Self-Powered InSe/SnS2 Van der Waals Photodetectors via Gas Molecular Physisorption. | Small Sci | 2026 | 41810041 | PubTator, text mining | PubMed |
| Propagation of THz magnons in a one-dimensional transition metal decorated holey graphyne strip with tunable bandgaps. | RSC Adv | 2026 | 41809672 | PubTator, text mining | PubMed |
| Reviewing the Peripheral and Central Mechanisms of Visceral Hypersensitivity in Intestinal Disorders. | Int J Med Sci | 2026 | 41799760 | PubTator, text mining | PubMed |
| Suzetrigine (a NaV1.8 inhibitor) versus placebo for acute postoperative pain: A systematic review and meta-analysis of randomized controlled trials. | Medicine (Baltimore) | 2026 | 41790692 | PubTator, text mining | PubMed |
| Comparative analysis of Nafion-functionalized few-layered vs. multilayered Ti3C2T x MXene/SnS2 nanoflowers for ammonia detection with enhanced selectivity. | RSC Adv | 2026 | 41782687 | PubTator, text mining | PubMed |
| Osteoarthritis: molecular pathogenesis and potential therapeutic options. | Signal Transduct Target Ther | 2026 | 41781374 | PubTator, text mining | PubMed |
| Regulating the layered structure of 2D FePS3 to achieve high-performance electrocatalytic urea degradation. | Nanoscale | 2026 | 41757856 | PubTator, text mining | PubMed |
| D-serine: A Multitalented Neuromodulator in Brain Function, Systemic Homeostasis, and Disease. | Cell Mol Neurobiol | 2026 | 41735678 | PubTator, text mining | PubMed |
| Orchestrating life's first community: molecular assembly by human milk oligosaccharides. | Gut Microbes | 2026 | 41715897 | PubTator, text mining | PubMed |
| Selective Nav1.8 inhibition by suzetrigine, a novel nonopioid analgesic for acute pain management: A systematic review and metanalysis. | Saudi J Anaesth | 2026 | 41710612 | PubTator, text mining | PubMed |
| Targeting Nav Channels for Pain Relief: Structural Insights and Therapeutic Opportunities. | Int J Mol Sci | 2026 | 41683608 | PubTator, text mining | PubMed |
| Magnetically Switchable Ferroelastic Phase Transition in Two-Dimensional Multiferroics. | Small | 2026 | 41636137 | PubTator, text mining | PubMed |
| Atomically Resolved Acoustic Dynamics Coupled with Magnetic Order in a Van der Waals Antiferromagnet. | Adv Mater | 2026 | 41622543 | PubTator, text mining | PubMed |
| Exceptionally selective voltage-sensor trapping of NaV1.5 channels by Mg-protoporphyrin impairs cancer cell migration. | Sci Rep | 2026 | 41611918 | PubTator, text mining | PubMed |
| Heterointerfacial and Architectural Engineering in MOF-Templated Corn-Like FePS3-ZnPS3-C@NC Anode for Durable Sodium Storage. | Small | 2026 | 41607235 | PubTator, text mining | PubMed |
| A dual-marker peripheral signature of IL-6 elevation and NEAT1 reduction in negative-symptom schizophrenia: a cross-sectional study. | Acta Neuropsychiatr | 2026 | 41572421 | PubTator, text mining | PubMed |
| A CMOS-Compatible Route to Wafer-Scale Van der Waals Magnets. | Small Methods | 2026 | 41566804 | PubTator, text mining | PubMed |
| Basal Plane Activation of SnS2 Thin-Film by Fluorine Doping for Selective Solar-Driven CO2 Reduction With Enhanced Quantum Efficiency. | Adv Sci (Weinh) | 2026 | 41560376 | PubTator, text mining | PubMed |
| Numerical modeling to enhance the efficiency of experimentally fabricated Sb2Se3-based solar cell. | RSC Adv | 2026 | 41542342 | PubTator, text mining | PubMed |
| Viewpoint: on the emergence of van der Waals magnets: a personal reflection. | J Phys Condens Matter | 2026 | 41505893 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/11280/papers?page=2